AAAAAA

   
Results: 1-11 |
Results: 11
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Authors: Hidalgo, M Siu, LL Nemunaitis, J Rizzo, J Hammond, LA Takimoto, C Eckhardt, SG Tolcher, A Britten, CD Denis, L Ferrante, K Von Hoff, DD Silberman, S Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J CL ONCOL, 19(13), 2001, pp. 3267-3279
Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study
Authors: van Oosterom, AT Judson, I Verweij, J Stroobants, S di Paola, ED Dimitrijevic, S Martens, M Webb, A Sciot, R Van Glabbeke, M Silberman, S Nielsen, OS
Citation: At. Van Oosterom et al., Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study, LANCET, 358(9291), 2001, pp. 1421-1423
Exercise hemodynamics of aortic prostheses: Comparison between stentless bioprostheses and mechanical valves
Authors: Silberman, S Shaheen, J Merin, O Fink, D Shapira, N Liviatan-Strauss, N Bitran, D
Citation: S. Silberman et al., Exercise hemodynamics of aortic prostheses: Comparison between stentless bioprostheses and mechanical valves, ANN THORAC, 72(4), 2001, pp. 1217-1221
Transradial catheterization: A word of caution
Authors: Merin, O Shapira, N Silberman, S Bitran, D
Citation: O. Merin et al., Transradial catheterization: A word of caution, J INVAS CAR, 12(3), 2000, pp. 142-143
Comparison between stentless xenografts and homografts
Authors: Silberman, S Shapira, N Bitran, D
Citation: S. Silberman et al., Comparison between stentless xenografts and homografts, ANN THORAC, 69(6), 2000, pp. 1989-1989
'Show Me a Hero' (Glazer's review of Belkin)
Authors: Weiss, HM Silberman, S
Citation: Hm. Weiss et S. Silberman, 'Show Me a Hero' (Glazer's review of Belkin), NY TIMES R, 1999, pp. 4-4
Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype inNIH 3T3 fibroblasts
Authors: Janulis, M Silberman, S Ambegaokar, A Gutkind, JS Schultz, RM
Citation: M. Janulis et al., Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype inNIH 3T3 fibroblasts, J BIOL CHEM, 274(2), 1999, pp. 801-813
Platelets - Preparations, transfusion, modifications, and substitutes
Authors: Silberman, S
Citation: S. Silberman, Platelets - Preparations, transfusion, modifications, and substitutes, ARCH PATH L, 123(10), 1999, pp. 889-894
Clinical and hemodynamic performance of the freestyle aortic root bioprosthesis - Discussion
Authors: Schor, JS",Cartier,"Accola, KD Schaff, HV Silberman, S Sintek, CF Kurlansky, PA Lytle, BW Gummert, JF
Citation: Kd. Schor, Js",cartier,"accola et al., Clinical and hemodynamic performance of the freestyle aortic root bioprosthesis - Discussion, ANN THORAC, 67(2), 1999, pp. 349-351
Comparison of exercise hemodynamics among nonstented aortic bioprostheses,mechanical valves, and normal native aortic valves
Authors: Silberman, S Shaheen, J Fink, D Tzivoni, D Rosenmann, D Shapira, N Strauss-Liviatan, N Bitran, D
Citation: S. Silberman et al., Comparison of exercise hemodynamics among nonstented aortic bioprostheses,mechanical valves, and normal native aortic valves, J CARDIAC S, 13(5), 1998, pp. 412-416
Aortic valve replacement using circulatory arrest
Authors: Silberman, S Fink, D Bitran, D
Citation: S. Silberman et al., Aortic valve replacement using circulatory arrest, ANN THORAC, 66(6), 1998, pp. 2158-2159
Risultati: 1-11 |